Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Experimental of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission

NCT02044952 is registered in ClinicalTrials.gov with Zhu Weiming as lead sponsor.

NCT NCT02044952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02044952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Experimental of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission
Lead sponsor
Zhu Weiming
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 31, 2014
Completion date
July 31, 2016
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, digestive system diseases, gastrointestinal diseases, inflammatory bowel diseases, intestinal diseases